News | Breast Density | September 13, 2016

Are You Dense Inc. Launches Spanish Language Breast Health Program

Educational resources in Spanish, including video, encourage Latina women to be informed about their breast health, especially fibroglandular density

September 13, 2016 — Are You Dense Inc., in collaboration with Madre Latina Inc., recently announced a new set of educational breast health resources in Spanish. Named E.M.P.O.W.E.R.E.D. (Early Matters: Providing Opportunities With Educational Resources for Early Detection), the resource set features educational literature and a video with English captions urging women to be smart about breast cancer screening options, including knowledge of their breast density for optimum breast health. A survivor's story, a call to breast health action from a Latina leader and a physician, frame the short video.

Yoellie Iglesias, director of Madre Latina Inc., said, "The video is empowering, giving women the ability to be ambassadors of our breast health." 

Obstetrician/gynecologist Claudia Grogean, M.D., said, "This video is a welcomed educational resource for my Hispanic and Latina patients and women across the globe."

Nancy M. Cappello, Ph.D., founder and director of Are You Dense Inc. and Are You Dense Advocacy Inc., also a video contributor, explained that dense breast tissue hides cancerous tumors on mammogram, making cancer difficult to detect until much further along. "Our mission is clear — first, ensuring that no woman suffers the tragedy of a preventable late-stage diagnosis and second, eliminating barriers to adjunct screening, such as ultrasound and MRI [magnetic resonance imaging]. We are especially grateful to the Connecticut Community Foundation for funding this targeted outreach effort." 

Also included in E.M.P.O.W.E.R.E.D. are a Breast Cancer Risk Checklist and a Patient Brochure. The checklist is designed for download so patients can track their personal risk factors, including breast density. The Patient Brochure provides fast facts about density and addresses questions about other common screening tools a patient may be recommended to have in addition to their mammogram.

The American Cancer Society reports breast cancer as the leading cause of cancer deaths in Hispanic/Latina women, as they are more likely to be diagnosed with advanced disease compared to white non-Hispanic population. A preliminary study by Beth A. Jones, Ph.D., MPH director, Smilow Screening & Prevention Program, assistant director Diversity/Health Equity, Yale Cancer Center and a collaborator on the EMPOWERED project, furthered these findings in Connecticut by examining mammography screening and understanding of dense breast tissue in this population. "I am gratified that our research motivated the launching of the EMPOWERED program for this population," added Jones.

For more information:

Related Content

Novel Technique May Significantly Reduce Breast Biopsies
News | Breast Biopsy Systems | January 17, 2019
A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce...
Digital Mammography Increases Breast Cancer Detection
News | Mammography | January 16, 2019
The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United...
Artificial Intelligence Used in Clinical Practice to Measure Breast Density
News | Artificial Intelligence | January 15, 2019
An artificial intelligence (AI) algorithm measures breast density at the level of an experienced mammographer,...
Sponsored Content | Videos | Breast Imaging | January 11, 2019
Supplemental screening with ABUS helps personalize breast care for women with dense breasts and offers advanced...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Breast Cancer Patients Have Less Heart Damage With Heart Drug and Trastuzumab
News | Cardio-oncology | January 03, 2019
Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage, according to a...
Opto-Acoustic Imaging Helps Differentiate Breast Cancer Molecular Subtypes
News | Ultrasound Women's Health | December 20, 2018
Seno Medical Instruments Inc. (Seno Medical) reported results of a study demonstrating that morphologic and functional...
Densitas Enters Platform Partnership With Blackford
News | Breast Density | December 19, 2018
Breast imaging analytics company Densitas Inc. announced the signing of a new Alliance Partner Agreement with Blackford...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RSNA Study Shows Real-Time Indicator Improves Mammographic Compression
News | Mammography | December 12, 2018
Sigmascreening recently announced that more than 100,000 women have had mammography exams with the Sensitive Sigma...